This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignees: Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt, Iowa State University Research Foundation Inc., University of Michigan. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2021
Title: Josef Lichtmannegger: Innovator in Copper-Related Disease Treatment
Introduction
Josef Lichtmannegger is a notable inventor based in Neuching, Germany. He has made significant contributions to the field of (bio-)medicine, particularly in the treatment of copper-related diseases. His innovative approach has the potential to improve the lives of many individuals suffering from these conditions.
Latest Patents
Lichtmannegger holds a patent for "Means and methods for treating copper-related diseases." This invention focuses on novel means and methods for depleting excess copper from organs and the circulation. The patent provides agents with a high copper binding affinity and stabilized forms thereof, along with a novel treatment regimen. This invention is particularly useful for treating Wilson Disease, as well as other related conditions.
Career Highlights
Throughout his career, Lichtmannegger has worked with esteemed organizations such as Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH and Iowa State University Research Foundation, Inc. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Lichtmannegger has collaborated with notable individuals in his field, including Hans Zischka and Alan Angelo Dispirito. These collaborations have further enriched his research and development efforts.
Conclusion
Josef Lichtmannegger's innovative work in treating copper-related diseases showcases his dedication to advancing medical science. His contributions have the potential to make a significant impact on the treatment of these conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile